MiR-371a-3p in cystic trophoblastic tumour of the testis: supporting a maturation phenomenon towards teratoma

被引：2
|
作者：
Lobo, Joao [1 ,2 ,3 ,4 ]
Tavares, Nuno Tiago [2 ,3 ]
Barros-Silva, Daniela [2 ,3 ]
Rosinha, Alina [5 ]
Morais, Antonio [6 ]
Jeronimo, Carmen [2 ,3 ,4 ]
Rodrigues, Angelo [1 ,2 ,3 ,4 ]
Henrique, Rui [1 ,2 ,3 ,4 ]
机构：
[1] Portuguese Oncol Inst Porto IPOP, Dept Pathol, Porto, Portugal
[2] Portuguese Oncol Inst Porto IPO Porto, IPO Porto Res Ctr GEBC CI IPOP, Canc Biol & Epigenet Grp, Porto, Portugal
[3] Prto Comprehens Canc Ctr P CCC, Porto, Portugal
[4] Univ Porto ICBAS UP, Inst Biomed Sci Abel Salazar, Dept Pathol & Mol Immunol, Porto, Portugal
[5] Portuguese Oncol Inst Porto IPOP, Dept Med Oncol, Porto, Portugal
[6] Portuguese Oncol Inst Porto IPOP, Dept Urol, Porto, Portugal
来源：
HISTOPATHOLOGY | 2023年 / 83卷 / 01期
关键词：
D O I：
10.1111/his.14929
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：151 / 154
页数：4
相关论文
共 50 条
  • [31] REFINEMENT OF THE SERUM MIR-371A-3P TEST FOR THE DETECTION OF CHEMOTHERAPY-NAIVE MINIMAL RESIDUAL TESTICULAR CANCER
    Lafin, John T.
    Amini, Armon
    Konneh, Bendu
    Savelyeva, Anna
    Piao, Jin
    Nuno, Michelle
    Scarpini, Cinzia G.
    Howard, Jeffrey M.
    Gerald, Thomas
    Coleman, Nicholas
    Murray, Matthew J.
    Frazier, Lindsay
    Amatruda, James F.
    Bagrodia, Aditya
    JOURNAL OF UROLOGY, 2022, 207 (05): : E772 - E772
  • [32] Plasma miR-371a-3p for detection of non-teratomatous viable germ cell tumor in testicular cancer
    Nappi, L.
    Thi, M.
    Eigl, B. J.
    Lum, A.
    Huntsman, D.
    Martin, C.
    O'Neil, B.
    Khalaf, D. J.
    Chi, K. N.
    Gleave, M. E.
    So, A.
    Black, P.
    Daneshmand, S.
    Nichols, C. R.
    Kollmannsberger, C. K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [33] The Diagnostic Accuracy of miR-371a-3p for Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis
    Liu, Qiangzhao
    Lian, Qiong
    Lv, Haidi
    Zhang, Xiaofeng
    Zhou, Fenghai
    MOLECULAR DIAGNOSIS & THERAPY, 2021, 25 (03) : 273 - 281
  • [34] Optimization of serum miR-371a-3p for the detection of chemotherapy-naive minimal residual germ cell tumor.
    Lafin, John T.
    Amini, Armon
    Konneh, Bendu
    Savelyeva, Anna
    Piao, Jin
    Nuno, Michelle
    Scarpini, Cinzia
    Howard, Jeffrey
    Gerald, Thomas
    Jia, Liwei
    Coleman, Nicholas
    Murray, Matthew
    Frazier, Lindsay Lindsay
    Amatruda, James F.
    Bagrodia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [35] Analytical Validation and Performance Characteristics of Molecular Serum Biomarkers, miR-371a-3p and miR-372-3p, for Male Germ Cell Tumors, in a Clinical Laboratory Setting
    Ye, Fei
    Feldman, Darren R.
    Valentino, Alisa
    So, Rachel
    Bromberg, Maria
    Khan, Shah
    Funt, Samuel A.
    Sheinfeld, Joel
    Solit, David B.
    Pessin, Melissa S.
    Peerschke, Ellinor I.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (08): : 867 - 877
  • [36] CLIMATE: Assessing the clinical utility of miR-371a-3p as a marker of residual disease in stage 1 testicular germ cell tumour (TGCT) following orchiectomy: ANZUP 1906.
    Conduit, Ciara
    Grimison, Peter S.
    Lewin, Jeremy Howard
    Hansen, Aaron Richard
    Lynam, James F.
    Weickhardt, Andrew James
    Parente, Phillip
    Campbell, David Colin
    Hong, Wei
    Marx, Gavin M.
    Heron, Orlaith Mary
    Kuchel, Anna
    McJannett, Margaret Mary
    Cusick, Thomas
    Fontela, Antoinette
    Haire, Sophie O.
    Zlatic, Kristina
    Davis, Ian D.
    Ben Tran
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males
    Spiller, Cassy M.
    Lobo, Joao
    Boellaard, Willem P. A.
    Gillis, Ad J. M.
    Bowles, Josephine
    Looijenga, Leendert H. J.
    CANCERS, 2020, 12 (03)
  • [38] Refining the serum miR-371a-3p test for viable germ cell tumor detection: Identification and definition of an indeterminate range.
    Bagrodia, Aditya
    Lafin, John T.
    Scarpini, Cinzia
    Konneh, Bendu
    Gerald, Thomas
    Nuno, Michelle
    Piao, Jin
    Savelyeva, Anna
    Jia, Liwei
    Murray, Sarah
    Cheng, Yun
    Margulis, Vitaly
    Woldu, Solomon L.
    Coleman, Nicholas
    Amatruda, James F.
    Frazier, Lindsay Lindsay
    Murray, Matthew
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [39] miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
    Thor, Anna
    Myklebust, Mette Pernille
    Bergdahl, Anna Grenabo
    Lundgren, Per-Olof
    Skokic, Viktor
    Almas, Bjarte
    Haugnes, Hege Sagstuen
    Tandstad, Torgrim
    Akre, Olof
    Cohn-Cedermark, Gabriella
    Dahl, Olav
    Kjellman, Anders
    JOURNAL OF UROLOGY, 2024, 212 (05): : 720 - 730
  • [40] Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer
    Lobo, Joao
    Leao, Ricardo
    Gillis, Ad J. M.
    van den Berg, Annette
    Anson-Cartwright, Lynn
    Atenafu, Eshetu G.
    Kuhathaas, Kopika
    Chung, Peter
    Hansen, Aaron
    Bedard, Philippe L.
    Jewett, Michael A. S.
    Warde, Padraig
    O'Malley, Martin
    Sweet, Joan
    Looijenga, Leendert H. J.
    Hamilton, Robert J.
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (03): : 483 - 491
12345